Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study

BACKGROUND: Preliminary evidence suggest clozapine is associated with more favorable impact on concurrent substance use disorder related outcomes in patients with concurrent schizophrenia spectrum disorders (SSD). At the same time, there is a dearth of evidence with regards to clozapine outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafizadeh, Reza, Frankow, Laura, Mahmood, Hajer, Poonia, Sukhpreet, Mathew, Nickie, Danilewitz, Marlon, Bousman, Chad A, Honer, William G, Schütz, Christian G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612371/
https://www.ncbi.nlm.nih.gov/pubmed/37539972
http://dx.doi.org/10.1177/02698811231191781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612371/
https://www.ncbi.nlm.nih.gov/pubmed/37539972
http://dx.doi.org/10.1177/02698811231191781

Ejemplares similares